Table of Contents page: Journal of Thoracic Oncology

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

In This Issue/Research Watch/News-in-Brief/News from the IASLC Tobacco Control Committee

Published in issue: August 2018

p1045-1052

Introduction to the Special Section: The Experience and Impact of Lung Cancer Stigma

Heidi A. Hamann,
Jean-Louis Pujol

Published in issue: August 2018

p1053-1054

BRAF Mutations—A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?

Surein Arulananda,
Paul Mitchell

Published online: July 03, 2018

p1055-1057

The Italian Nivolumab Expanded Access Program Confirms the Limitations of Single-Agent PD-1 Inhibition in EGFR-Mutant and Never-Smoking Patients with NSCLC

Aaron Lisberg,
Edward B. Garon

Published online: July 03, 2018

p1058-1059

Impact of PD-L1 Expression in EGFR-Positive NSCLC? The Answer Remains the Same…

David F. Heigener,
Martin Reck

Published online: July 03, 2018

p1060-1061

Review Articles

Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum

Heidi A. Hamann,
Elizabeth S. Ver Hoeve,
Lisa Carter-Harris,
Jamie L. Studts,
Jamie S. Ostroff

Published online: May 22, 2018

p1062-1075

Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors

Ioannis Gkiozos,
Alexandra Kopitopoulou,
Alexandros Kalkanis,
Ioannis N. Vamvakaris,
Marc A. Judson,
Konstantinos N. Syrigos

Published online: May 12, 2018

p1076-1082

Original Articles

Cancer Control

Racial-Ethnic Disparities in End-of-Life Care Quality among Lung Cancer Patients: A SEER-Medicare–Based Study

Siddharth Karanth,
Suja S. Rajan,
Gulshan Sharma,
Jose-Miguel Yamal,
Robert O. Morgan

Published online: May 10, 2018

p1083-1093

Screening/Epidemiology

Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia

Stephen Wade,
Marianne Weber,
Michael Caruana,
...
Nicole Rankin,
Kwun Fong,
Karen Canfell

Published online: April 21, 2018

p1094-1105

Translational Oncology

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication

Hansang Lee,
Ho Yun Lee,
Jong-Mu Sun,
...
Jin Seok Ahn,
Keunchil Park,
Myung-Ju Ahn

Published online: May 15, 2018

p1106-1112

PD-L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections

Enrico Munari,
Giuseppe Zamboni,
Gianluigi Lunardi,
...
Paola Vacca,
Lorenzo Moretta,
Giuseppe Bogina

Published online: April 25, 2018

p1113-1120

Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose

Kamran A. Ahmed,
Jacob G. Scott,
John A. Arrington,
...
Steven A. Eschrich,
Thomas J. Dilling,
Javier F. Torres-Roca

Published online: May 04, 2018

p1121-1127

BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

Elizabeth Dudnik,
Nir Peled,
Hovav Nechushtan,
...
Laila C. Roisman,
Jair Bar
on behalf of the Israel Lung Cancer Group

Published online: April 30, 2018

p1128-1137

Non–Small Cell Lung Cancer

A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

A. Lisberg,
A. Cummings,
J.W. Goldman,
...
L. Ma,
C. Adame,
Edward B. Garon

Published online: June 01, 2018

p1138-1145

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Marina Chiara Garassino,
Alain Jonathan Gelibter,
Francesco Grossi,
...
Diana Giannarelli,
Giuseppe Lo Russo,
Filippo de Marinis

Published online: May 03, 2018

p1146-1155

Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer

Louis Fehrenbacher,
Joachim von Pawel,
Keunchil Park,
...
Alan Sandler,
Marcus Ballinger,
Fabrice Barlesi

Published online: May 17, 2018

p1156-1170

Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC

Steven E. Schild,
Herbert H. Pang,
Wen Fan,
...
Jeffrey D. Bradley,
Karen Kelly,
Xiaofei Wang

Published online: April 21, 2018

p1171-1182

The Impact of Staging by Positron-Emission Tomography on Overall Survival and Progression-Free Survival in Patients With Locally Advanced NSCLC

Everett E. Vokes,
Ramaswamy Govindan,
Neill Iscoe,
...
Nadia Chouaki,
Marianna Koczywas,
Suresh Senan

Published online: May 04, 2018

p1183-1188

Mesothelioma

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

F. Galateau Salle,
N. Le Stang,
A.G. Nicholson,
...
S. Lantuejoul,
V. Rusch,
N. Girard

Published online: April 30, 2018

p1189-1203

Thymoma

Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma

Dwight Owen,
Benjamin Chu,
Amy M. Lehman,
...
Jennifer H. Yearley,
Konstantin Shilo,
Gregory A. Otterson

Published online: April 24, 2018

p1204-1212

Brief Report on the Detection of the EGFR T790M Mutation in Exhaled Breath Condensate from Lung Cancer Patients

Robert J. Smyth,
Sinead M. Toomey,
Alexander Sartori,
...
Oscar S. Breathnach,
Ross K. Morgan,
Bryan T. Hennessy

Published online: May 08, 2018

p1213-1216

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report

Yuki Owada-Ozaki,
Satoshi Muto,
Hironori Takagi,
...
Takao Isogai,
Shinya Watanabe,
Hiroyuki Suzuki

Published online: April 11, 2018

p1217-1221

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion–Positive Advanced NSCLC

Bianca van Veggel,
Adrianus J. de Langen,
Sayed M.S. Hashemi,
...
Daniëlle A.M. Heideman,
Erik Thunnissen,
Egbert F. Smit

Published online: April 24, 2018

p1222-1226

A Case of Adenocarcinoma of the Lung With EGFR T790 Mutation Presenting With Chylous Ascites

Kentaro Nakashima,
Yu Hara,
Takashi Sato,
Masaharu Shinkai,
Takeshi Kaneko

Published online: April 06, 2018

p1227-1228

Erratum to: Kiesgen S, Chicaybam L, Chintala N.K, Adusumilli P.S. Chimeric antigen receptor (CAR) t-cell therapy for thoracic malignancies. J Thorac Oncol. 2018;13(1):16-26.

Published in issue: August 2018

p1229

Erratum to: Derks JL, Leblay N, Lantuejoul S, Dingemans A-M, Speel, E-JM, Fernandez-Cuesta L. New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management. J Thorac Oncol. 2018;13(6):752-766.

Published in issue: August 2018

p1229

Erratum to: Kerr KM. The PD-L1 immunohistochemistry biomarker: two steps forward, one step back? J Thorac Oncol. 2018;13(3):291-294.

Published in issue: August 2018

p1230

An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib

Daniel L. Abravanel,
Mizuki Nishino,
Lynette M. Sholl,
Chiara Ambrogio,
Mark M. Awad

Published online: April 06, 2018

e131-e133

Disease Response with the Addition of Platinum-Based Chemotherapy to Pembrolizumab after Progression on Pembrolizumab Monotherapy in PD-L1–Expressing Non–Small Cell Lung Cancer

Christine A. Garcia,

Sanja Dacic,

Liza C. Villaruz

Published in issue: August 2018

e135-e136

Tyrosine Kinase Inhibition in a Lung Adenocarcinoma Patient With Dual G719S and S768I EGFR Mutations

Jacob Zaemes,
Richard D. Hall,
Ryan D. Gentzler

Published in issue: August 2018

e136-e137

Myositis in a Patient with Advanced Lung Cancer Treated with Osimertinib

Shusei Fujioka,
Takamasa Kitajima,
Ryo Itotani

Published in issue: August 2018

e137-e139

Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M

Satoru Senoo,
Kadoaki Ohashi,
Kazuya Nishii,

Naofumi Hara,
Hirohisa Kano,

Kiichiro Ninomiya,
Yoshinobu Maeda,

Katsuyuki Kiura

Published in issue: August 2018

e140-e142

Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment

Antonella Vigani,

Maria Pia Pistillo,

Vincenzo Fontana,

Ugo Giannoni,
Ilan Rosenberg,

Pier Aldo Canessa,

Giovanni Berisso,

Paola Ferro,
Maria Cristiana Franceschini,
Marika Tonarelli,
Silvio Roncella

Published in issue: August 2018

e143-e145

Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation

Sara Baglivo,
Biagio Ricciuti,
Vienna Ludovini,
...
Annamaria Siggillino,
Andrea De Giglio,
Rita Chiari

Published in issue: August 2018

e145-e147

Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion

J. Kevin Hicks,

Theresa Boyle,

Lee A. Albacker,
Russell Madison,
Garrett Frampton,

Benjamin C. Creelan

Published in issue: August 2018

e148-e150

Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma

Hyun-Sung Lee,
Cynthia Y. Truong,
Bryan M. Burt

Published in issue: August 2018

e150-e152

Late Gastrointestinal Toxicity During Nivolumab Therapy in Non–Small Cell Lung Cancer: A Rare Case of Inflammatory Bowel Disease

Giorgia Guaitoli,
Cinzia Baldessari,
Chiara Tomasello,
Fausto Barbieri,
Stefano Cascinu,
Federica Bertolini,

Anna Maria Cesinaro

Published in issue: August 2018

e152-e153

Minimal Change Disease Induced by Lorlatinib

Maureen Betton,

Valérie Gounant,

Aurélie Sannier,

Guillaume Hanouna,

Jean-Michel Goujon,

Solenn Brosseau,

Gérard Zalcman,

Jonathan M. Chemouny

Published in issue: August 2018

e154-e156

Editorial Board

Published in issue: August 2018

A1-A2

Board of Directors

Published in issue: August 2018

A4

Meeting Announcements

Published in issue: August 2018

A6

August 2018

Editorials

Review Articles

Original Articles

Cancer Control

Screening/Epidemiology

Translational Oncology

Non–Small Cell Lung Cancer

Mesothelioma

Thymoma

Brief Reports

Image of the Month

Errata

Case Report

Letters to the Editor

Frontmatter